Avalo Therapeutics (AVTX) Stock Chart & Stock Price History $5.01 +0.07 (+1.42%) Closing price 07/3/2025 01:33 PM EasternExtended Trading$5.01 0.00 (0.00%) As of 07/3/2025 04:46 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Avalo Therapeutics Stock Price Performance The Avalo Therapeutics (AVTX) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 56.96%, with a year-to-date return of -32.57%. In the past month, the stock has increased 15.17%, reflecting recent market activity. As of the latest close, Avalo Therapeutics traded at $5.01 with a market cap of $54.26 million and volume of 22,006 shares. Receive AVTX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Avalo Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+4.81%1 Month Performance+15.17%3 Month Performance-13.62%Year-To-Date Performance-32.57%1 Year Performance-56.96% AVTX Stock Chart for Friday, July, 4, 2025 AVTX Chart by TradingView Avalo Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/04/2025$5.01$5.01$5.02$4.9122,006 shs$54.25 million07/03/2025$4.94$5.01+1.42%$5.02$4.9122,006 shs$54.26 million07/02/2025$4.84$4.94+2.07%$5.02$4.76554,180 shs$53.50 million07/01/2025$4.99$4.84-3.01%$5.05$4.8052,820 shs$52.42 million06/30/2025$4.78$4.99+4.39%$5.00$4.7670,881 shs$54.04 million06/27/2025$4.76$4.78+0.42%$4.85$4.5592,801 shs$51.77 million06/26/2025$4.79$4.76-0.63%$4.83$4.5352,797 shs$51.55 million06/25/2025$4.95$4.79-3.23%$5.02$4.50264,268 shs$51.87 million06/24/2025$4.79$4.95+3.34%$4.95$4.7369,111 shs$53.61 million06/23/2025$4.64$4.79+3.23%$4.90$4.5552,240 shs$51.88 million Get the Latest News and Ratings for AVTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Avalo Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 06/20/2025$4.76$4.64-2.52%$4.92$4.5833,833 shs$50.24 million06/19/2025$4.76$4.76$4.90$4.4740,654 shs$51.55 million06/18/2025$4.47$4.76+6.49%$4.90$4.4740,654 shs$51.55 million06/17/2025$4.61$4.47-3.04%$4.77$4.4666,489 shs$48.40 million06/16/2025$4.84$4.61-4.75%$4.90$4.6028,727 shs$49.92 million06/13/2025$4.88$4.84-0.82%$4.95$4.6844,205 shs$52.41 million06/12/2025$4.71$4.88+3.61%$4.95$4.6246,938 shs$52.84 million06/11/2025$4.82$4.71-2.28%$4.98$4.5938,289 shs$51 million06/10/2025$4.56$4.82+5.70%$5.00$4.60129,030 shs$52.19 million06/09/2025$4.10$4.56+11.22%$4.69$4.20197,319 shs$49.38 million06/06/2025$4.33$4.10-5.31%$4.49$4.0689,023 shs$44.40 million06/05/2025$4.35$4.33-0.46%$4.50$4.15495,961 shs$46.89 million06/04/2025$4.40$4.35-1.14%$4.55$4.1349,558 shs$47.10 million06/03/2025$4.35$4.40+1.15%$4.48$4.2769,357 shs$47.64 million Related Companies Monopar Therapeutics Stock Chart Y-mAbs Therapeutics Stock Chart CARGO Therapeutics Stock Chart GENFIT Stock Chart ProKidney Stock Chart Bright Minds Biosciences Stock Chart 4D Molecular Therapeutics Stock Chart Kodiak Sciences Stock Chart AC Immune Stock Chart Citius Oncology Stock Chart Receive AVTX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Avalo Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:AVTX) was last updated on 7/4/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredElon’s RevengeElon Musk and President Trump's new feud is all over the news... But what no one has reported – yet – is th...Altimetry | Sponsored379 passengers walked away from thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredI was wrong about TrumpI made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his ...Porter & Company | SponsoredGold: Now legal tender in many statesThe perfect gold play right now? (currently under $10) Everything in the news now lines up perfectly for an...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Avalo Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Avalo Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
